SRD5A2
protein-codingsteroid 5 alpha-reductase 2, the group of Steroid 5-alpha reductase family
Gene summary
This gene encodes a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The encoded protein is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in this gene can result in male pseudohermaphroditism, specifically pseudovaginal perineoscrotal hypospadias (PPSH). [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~58.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009923
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009923
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009923
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Endocrine; Genitourinary; Oncologic
Intervention: Endocrine; Genitourinary; Oncologic
Rationale: Hormonal treatment may be beneficial related to phenotypic gender characteristics; Due to risk of gonadal malignancy, prophlactic measures (related to gonadal tumors) may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SRD5A2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000348.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 72 | 1 | 75 | ||
| missense | 22 | 32 | 43 | 6 | 3 | 106 |
| nonsense | 12 | 5 | 17 | |||
| start loss | 1 | 1 | ||||
| frameshift | 18 | 4 | 1 | 1 | 24 | |
| splice donor/acceptor (+/-2bp) | 3 | 5 | 8 | |||
| Total | 56 | 46 | 46 | 79 | 4 | 231 |
Highest pathogenic variant AF is 0.00028507438
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000339.2 | 5 | MANE Select | |
| Ensembl | ENSP00000477587.1 | 5 | MANE Select | |
| Ensembl | ENSP00000552701.1 | 6 | Standard | |
| Ensembl | ENSP00000552701.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Steroid hormone biosynthesis - Homo sapiens (human)
- Prostate cancer - Homo sapiens (human)
- Metabolism of lipids
- Androgen and estrogen biosynthesis and metabolism
- Metabolism
Biological Process
- androgen biosynthetic process
- steroid catabolic process
- cell-cell signaling
- androgen metabolic process
- male gonad development
Molecular Function
- 3-oxo-5-alpha-steroid 4-dehydrogenase activity
- sterol 5-alpha reductase activity
- oxidoreductase activity
- testosterone dehydrogenase [NAD(P)] activity
- amide binding
Cellular Component
- endoplasmic reticulum membrane
- integral component of membrane
- organelle membrane
- neuronal cell body
- cell body fiber
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Converts testosterone (T) into 5-alpha- dihydrotestosterone (DHT) and progesterone or corticosterone into their corresponding 5-alpha-3-oxosteroids. It plays a central role in sexual differentiation and androgen physiology. {ECO:0000269|PubMed:10898110}.;
- Disease
- DISEASE: Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600]: A form of male pseudohermaphroditism in which 46,XY males show ambiguous genitalia at birth, including perineal hypospadias and a blind perineal pouch, and develop masculinization at puberty. The name of the disorder stems from the finding of a blind-ending perineal opening resembling a vagina and a severely hypospadiac penis with the urethra opening onto the perineum. {ECO:0000269|PubMed:10718838, ECO:0000269|PubMed:10898110, ECO:0000269|PubMed:10999800, ECO:0000269|PubMed:12843198, ECO:0000269|PubMed:15064320, ECO:0000269|PubMed:1522235, ECO:0000269|PubMed:15528927, ECO:0000269|PubMed:15770495, ECO:0000269|PubMed:16098368, ECO:0000269|PubMed:16181229, ECO:0000269|PubMed:7554313, ECO:0000269|PubMed:8626825, ECO:0000269|PubMed:8768837, ECO:0000269|PubMed:9208814, ECO:0000269|PubMed:9745434, ECO:0000269|PubMed:9843052}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.319
Essentials
- Indispensability pred.
- N
- Indispensability score
- 0.00567